Research Article

Protective Effects of BDNF against C-Reactive Protein-Induced Inflammation in Women

Table 1

Clinical characteristics of cohort with separate comparisons between middle and high hsCRP groups with the low hsCRP group.

hsCRP groups ( per group)
LowMidHigh
(≤3 mg/L)(>3–20 mg/L)(>20 mg/L)
MeanMeanMean

Age (y)49.8 (8.8)49.8 (8.8)49.8 (8.8)
hsCRP1−0.46 (1.0)1.87 (0.5)3.4 (0.4)
8-oxodG0.16 (0.04)0.17 (0.04)0.18 (0.04)
BMI26.8 (5.1)34.74 (9)39.6 (12)
Weight271.7 (14.6)93.2 (23.7)103.0 (33)
Waist size392.4 (13.5)106.9 (17.4)115 (23.4)
Hip size3102.7 (13.3)115.8 (17.6)124.4 (21)
Waist-hip ratio0.9 (0.08)0.92 (0.07)0.92 (0.08)
Diastolic BP471.5 (11.7)75.1 (11.3)69.9 (8.8)
Systolic BP4118.6 (18.2)126.4 (18.5)125.5 (20.4)#
Pulse pressure47.1 (13.0)51.3 (14.4)55.6 (15.8)
Total cholesterol5187.1 (34.9)196.1 (43.4)182.2 (45.9)
LDL5104.1 (34.7)115.5 (37.4)108.9 (43.8)
HDL560.3 (16.1)52.5 (14)47.7 (13.3)
Triglycerides5114.2 (81.2)140 (74.6)#127.8 (61.3)
Creatinine50.96 (0.9)0.87 (0.19)0.84 (0.2)
Glucose594.2 (10.1)100.9 (17.2)150.6 (81)
Insulin610.3 (6.9)12.3 (8.8)17.2 (12.7)
LDH7160.4 (32.3)178.2 (36.3)163.1 (34.8)
eGFR86.3 (18.5)85.9 (21.5)90.9 (25.4)
BDNF88.37 (22.5)8.57 (18.6)38.04 (27.2)#

Means and standard deviations () are indicated.
1 in mg/L.
2kg.
3cm.
4mm Hg.
5mg/dL.
6IU/mL.
7U/L.
8ng/mL.
#; ;  ; .